Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

$66.14 -1.17 (-1.74%)
As of 07/11/2025 04:10 PM Eastern

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Key Stats

Today's Range
$66.14
$66.79
50-Day Range
$59.58
$67.31
52-Week Range
$54.52
$72.84
Volume
3,055 shs
Average Volume
7,532 shs
Market Capitalization
$230.17 million
Assets Under Management
$229.54 million
Dividend Yield
0.24%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.56%0.51%0.53%
Other Expenses0.08%0.47%0.56%0.59%0.56%
Total Expense0.58%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.58%0.60%0.63%0.58%0.60%
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

PBE ETF News Headlines

PBE Invesco Biotechnology & Genome ETF
Invesco Dynamic Biotech & Genome ETF (PBE)
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
See More Headlines

PBE ETF - Frequently Asked Questions

Invesco Biotechnology & Genome ETF's stock was trading at $66.53 at the beginning of 2025. Since then, PBE shares have decreased by 0.6% and is now trading at $66.14.

Top institutional investors of Invesco Biotechnology & Genome ETF include YHB Investment Advisors Inc. (0.70%) and Wealth Enhancement Advisory Services LLC (0.14%).

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Biotechnology & Genome ETF investors own include Micron Technology (MU), Pfizer (PFE), Devon Energy (DVN), Intel (INTC), Activision Blizzard (ATVI), NVIDIA (NVDA) and Bristol Myers Squibb (BMY).

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
33

Fund Statistics

Assets Under Management
$229.54 million
Average Daily Volume
$5.41 thousand
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
10
Put Options
5
Call Options
10
Short Interest
1,400 shs

Miscellaneous

Beta
0.76
Creation Unit
10,000
Creation Fee
$500.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure


This page (NYSEARCA:PBE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners